Episode #19 - High Truths on Alcohol with Dr. George Koob, Director of NIAAA

Episode 19 May 03, 2021 00:53:50
Episode #19 - High Truths on Alcohol with Dr. George Koob, Director of NIAAA
High Truths on Drugs and Addiction
Episode #19 - High Truths on Alcohol with Dr. George Koob, Director of NIAAA

Show Notes

Alcohol Use Disorder remains the largest cause of substance use disorder in our country. Sadly, the COVID pandemic has exacerbated the problem. There are science based dietary guidelines for alcohol consumption with definitions on how much is one drink. Test yourself to find out if you are a High Risk drinker by using the ReThinking Drinking calculators. Listen to Dr. George Koob, the leading scientist in the world on alcohol as he explains the pandemic effects on alcoholism as well as innovative solutions.

George F. Koob, Ph.D., is an internationally-recognized expert on alcohol and stress, and the neurobiology of alcohol and drug addiction. He is the Director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), where he provides leadership in the national effort to reduce the public health burden associated with alcohol misuse. As NIAAA Director, Dr. Koob oversees a broad portfolio of alcohol research ranging from basic science to epidemiology, diagnostics, prevention, and treatment.

Dr. Koob earned his doctorate in Behavioral Physiology from Johns Hopkins University in 1972. Prior to taking the helm at NIAAA, he served as Professor and Chair of the Scripps’ Committee on the Neurobiology of Addictive Disorders and Director of the Alcohol Research Center at the Scripps Research Institute. Early in his career, Dr. Koob conducted research in the Department of Neurophysiology at the Walter Reed Army Institute of Research and in the Arthur Vining Davis Center for Behavioral Neurobiology at the Salk Institute for Biological Studies. He was a post-doctoral fellow in the Department of Experimental Psychology and the MRC Neuropharmacology Unit at the University of Cambridge.

Dr. Koob began his career investigating the neurobiology of emotion, particularly how the brain processes reward and stress. He subsequently applied basic research on emotions, including on the anatomical and neurochemical underpinnings of emotional function, to alcohol and drug addiction, significantly broadening knowledge of the adaptations within reward and stress neurocircuits that lead to addiction. This work has advanced our understanding of the physiological effects of alcohol and other substance use and why some people transition from use to misuse to addiction, while others do not. Dr. Koob has authored more than 650 peer-reviewed scientific papers and is a co-author of The Neurobiology of Addiction, a comprehensive textbook reviewing the most critical neurobiology of addiction research conducted over the past 50 years.

Dr. Koob is the recipient of many prestigious honors and awards for his research, mentorship, and international scientific collaboration. In 2018 Dr. Koob received the E.M. Jellinek Memorial Award for his outstanding contributions to understanding the behavioral course of addiction. In 2017 Dr. Koob was elected to the National Academy of Medicine(NAM).  In 2016 the government of France awarded Dr. Koob with the insignia of Chevalier de la Légion d’honneur (Knight of the Legion of Honor) for developing scientific collaborations between France and the United States.   [View the video: World-class scientist Dr Koob receives the Legion of Honor.] 

In addition, Dr. Koob previously received the Research Society on Alcoholism (RSA) Seixas Award for extraordinary service in advancing alcohol research; the RSA Distinguished Investigator Award; the RSA Marlatt Mentorship Award; the Daniel Efron Award for excellence in basic research and the Axelrod Mentorship Award, both from the American College of Neuropsychopharmacology; the NIAAA Mark Keller Award for his lifetime contributions to our understanding of the neurobiology of alcohol use disorder; and an international prize in the field of neuronal plasticity awarded by La Fondation Ipsen.

Other Episodes

Episode 37

September 06, 2021 01:02:59
Episode Cover

Episode # 37 High Truths with Dr. Robert Hendrickson on Oregon Drug Laws

  What is going on with Oregon Drug Laws? The state of Oregon made history, the first state in the United States to decriminalize the possession of all hard drugs on November 2020.  Marijuana was legalized in Oregon since 2014. Is this a good idea, a bad idea, or a yet to be determined social experiment? Oregon Measure 110, a ballot initiative funded by the Drug Policy Alliance, an advocacy group that promotes drug normalization, and passed with more than 58% of the vote. Possession of heroin, cocaine, meth, ecstasy or other drugs is no longer a criminal offense in Oregon. Possession may be a civil, not a criminal violation that may result in a fine or court ordered therapy, but not jail. People in Oregon can carry small amounts of drugs. What is a small amount? Less than 1g of heroin, less than 2 g of meth, less than 40 pills of oxycodone.  You can judge if you think that is small or large. Robert Henrickson, MD Robert Hendrickson is the Program Director for the fellowship in Medical Toxicology. Dr. Hendrickson is board certified in both Emergency Medicine and Medical Toxicology. He practices Emergency Medicine at the Oregon Health and Science University (OHSU), and is a Medical Toxicology inpatient consultant at OHSU and the Doernbecher Children’s Hospital (DCH). Dr. Hendrickson completed medical school at the State University of New York Downstate Medical Center / Kings County Hospital in Brooklyn, NY. He completed his residency in Emergency Medicine and fellowship in Medical Toxicology at the Medical College of Pennsylvania in Philadelphia, PA. He joined the OHSU Emergency Department and the Oregon Poison Center in 2002. Dr. Hendrickson has received numerous teaching ...


Episode 55

January 10, 2022 00:58:45
Episode Cover

Episode #55 High Truths on Drugs and Addiction with Dr. Nora Volkow

Listen to Dr. Nora Volkow’s discussion with Dr. Roneet Lev on the gold standard for addiction, substance use disorder treatment, innovations in drug treatment, naloxone, emergency treatment, stigma, decriminalization, marijuana, and more.  This podcast includes Dr. Nora Volkow  keynote presentation at the Western Regional Opioid & Stimulant Summit of November 2021. Nora D. Volkow, M.D., is Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. NIDA is the world’s largest funder of research on the health aspects of drug use and addiction. Dr. Volkow’s work has been instrumental in demonstrating that drug addiction is a brain disorder. As a research psychiatrist, Dr. Volkow pioneered the use of brain imaging to investigate how substance use affects brain functions. In particular, her studies have documented that changes in the dopamine system affect the functions of frontal brain regions involved with reward and self-control in addiction. She has also made important contributions to the neurobiology of obesity, ADHD, and aging. Dr. Volkow was born in Mexico and earned her medical degree from the National University of Mexico in Mexico City, where she received the Robins Award for best medical student of her generation. Her psychiatric residency was at New York University, where she earned a Laughlin Fellowship from The American College of Psychiatrists as one of 10 outstanding psychiatric residents in the United States. Much of her professional career was spent at the Department of Energy’s Brookhaven National Laboratory in Upton, New York, where she held several leadership positions including Director of Nuclear Medicine, Chairman of ...


Episode 93

October 03, 2022 00:53:16
Episode Cover

Episode # 93 High Truths on Drugs and Addiction with Pamela McColl and the Pied Pipers of Pot

Pamela McColl met the Pied Pipers of Pot and watched them lead Canada, American and a global following of marijuana. Where there warning signs of the medical and societal harms before legalization? Pamela McColl  https://en.wikipedia.org/wiki/Pamela_McColl Principal and Publisher, Grafton and Scratch  Pamela's Book The Pied Pipers of Pot: Protecting Youth from the Marijuana Industry When the product should not be used according to Pamela's Research Cannabis should not be used if you: are under the age of 25 are allergic to any cannabinoid or to smoke have serious liver, kidney, heart or lung disease have a personal or family history of serious mental disorders such as schizophrenia, psychosis, depression, or bipolar disorder are pregnant, are planning to get pregnant, or are breast-feeding are a man who wishes to start a family have a history of alcohol or drug abuse or substance dependence Talk to your health care practitioner if you have any of these conditions. There may be other conditions where this product should not be used, but which are unknown due to limited scientific information. ...